2016
DOI: 10.1007/s11469-016-9655-5
|View full text |Cite
|
Sign up to set email alerts
|

Buprenorphine-Naloxone in the Treatment of Codeine Dependence: a Scoping Review of Clinical Case Presentations

Abstract: Misuse of prescribed and over the counter (OTC) codeine containing medicines is an increasing public health concern in recent times. Studies have called for low threshold treatment services for individuals experiencing codeine dependence using buprenorphine

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2017
2017
2017
2017

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 45 publications
(15 reference statements)
0
1
0
Order By: Relevance
“…[14,15,25] Availability of opioid agonists should probably be expanded to low-threshold services in the treatment of codeine dependence. [26] The training needs of treatment providers should be addressed as a matter of urgency to cover best practices for managing codeine misuse and dependence, including detoxification modalities, pharmacotherapy maintenance treatment, psychosocial support and ensuring proper aftercare. [24] Given the relatively low numbers of individuals in treatment for codeine-related problems [5] and the possible barriers that may make it harder for them to access treatment, active steps are needed, in particular to address denial of the problem and fear of being stigmatised.…”
Section: Recommendationsmentioning
confidence: 99%
“…[14,15,25] Availability of opioid agonists should probably be expanded to low-threshold services in the treatment of codeine dependence. [26] The training needs of treatment providers should be addressed as a matter of urgency to cover best practices for managing codeine misuse and dependence, including detoxification modalities, pharmacotherapy maintenance treatment, psychosocial support and ensuring proper aftercare. [24] Given the relatively low numbers of individuals in treatment for codeine-related problems [5] and the possible barriers that may make it harder for them to access treatment, active steps are needed, in particular to address denial of the problem and fear of being stigmatised.…”
Section: Recommendationsmentioning
confidence: 99%